Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Efficacy and Safety of Admilparant, an LPA1 Antagonist, in Pulmonary Fibrosis: A Phase 2 Randomized Clinical Trial.
Evaluating a decision tool for diagnosing diastolic dysfunction and estimation of left ventricular filling pressures in the presence of mitral annular calcium.
Evaluation of the Cost-effectiveness of Drug Treatment for Alzheimer Disease in a Simulation Model That Includes Caregiver and Societal Factors.
Rare genetic variants in the CFI gene are associated with advanced age-related macular degeneration and commonly result in reduced serum factor I levels.
Giant asymptomatic primary esophageal schwannoma.
See All 6 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Giant asymptomatic primary esophageal schwannoma.
Kassis ES, Bansal S, Perrino C, Walker JP, Hitchcock C, Ross P, Daniel VC. Giant asymptomatic primary esophageal schwannoma. Ann Thorac Surg. 2012 Apr; 93(4):e81-3.
View in:
PubMed
subject areas
Aged
Esophageal Neoplasms
Esophagectomy
Fluorodeoxyglucose F18
Humans
Multimodal Imaging
Neurilemmoma
Positron-Emission Tomography
Radiopharmaceuticals
Tomography, X-Ray Computed
authors with profiles
Carmen Perrino MD